Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of SXR1096 Cream for Patients with Netherton Syndrome
FranceStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
FranceStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
FranceStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
FranceStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
FranceStudy on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments
FranceStudy on the Effectiveness and Safety of Bevacizumab, Atezolizumab, and RO7247669 in Patients with Resectable Liver Cancer
FranceStudy of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
FranceStudy of Tislelizumab, Surzebiclimab, and LBL-007 for Patients with Recurrent or Metastatic Head and Neck Cancer
FranceStudy on the Effects and Safety of PLX038 for Patients with Advanced or Metastatic Triple-Negative Breast Cancer
FranceStudy on Tegoprubart for Preventing Kidney Transplant Rejection in Patients
FranceStudy on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
